These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8948680)

  • 1. Pelvic osteomyelitis in a sickle-cell patient receiving deferoxamine.
    McLean TW; Kurth S; Gee B
    Am J Hematol; 1996 Dec; 53(4):284-5. PubMed ID: 8948680
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary embolism developing in patients with sickle cell disease on hypertransfusion and IV deferoxamine chelation therapy.
    Sheth S; Ruzal-Shapiro C; Hurlet-Jensen A; Piomelli S; Berdon WE
    Pediatr Radiol; 1997 Dec; 27(12):926-8. PubMed ID: 9388284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron chelation therapy for patients with sickle cell disease and iron overload.
    Inati A; Khoriaty E; Musallam KM; Taher AT
    Am J Hematol; 2010 Oct; 85(10):782-6. PubMed ID: 20721892
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
    Kalpatthi R; Peters B; Kane I; Holloman D; Rackoff E; Disco D; Jackson S; Laver JH; Abboud MR
    Pediatr Blood Cancer; 2010 Dec; 55(7):1338-42. PubMed ID: 20981690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare case of osteomyelitis of the sternum in an adult with sickle cell disease.
    Blokh I; Sobti P; Zinn H; Burack J; Ajiboye P; Solomon W; Gillette P; Braverman AS
    Hemoglobin; 2001 Feb; 25(1):111-3. PubMed ID: 11300345
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron overload? In sickle cell disease?
    Day S; Dancy R; Kelly K; Wang W
    MCN Am J Matern Child Nurs; 1993; 18(6):330-5. PubMed ID: 8295522
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients.
    Hilliard LM; Williams BF; Lounsbury AE; Howard TH
    Am J Hematol; 1998 Sep; 59(1):28-35. PubMed ID: 9723573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusional iron overload and iron chelation therapy in thalassemia major and sickle cell disease.
    Marsella M; Borgna-Pignatti C
    Hematol Oncol Clin North Am; 2014 Aug; 28(4):703-27, vi. PubMed ID: 25064709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.
    Vichinsky E; Onyekwere O; Porter J; Swerdlow P; Eckman J; Lane P; Files B; Hassell K; Kelly P; Wilson F; Bernaudin F; Forni GL; Okpala I; Ressayre-Djaffer C; Alberti D; Holland J; Marks P; Fung E; Fischer R; Mueller BU; Coates T;
    Br J Haematol; 2007 Feb; 136(3):501-8. PubMed ID: 17233848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of phlebotomy and subcutaneous bolus injection of deferoxamine for the treatment of anemic patients with iron overload.
    Franchini M; Gandini G; Girelli D; Lippi G; de Gironcoli M; Aprili G
    Haematologica; 2001 Aug; 86(8):873-4. PubMed ID: 11524250
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload.
    Singer ST; Quirolo K; Nishi K; Hackney-Stephens E; Evans C; Vichinsky EP
    J Clin Apher; 1999; 14(3):122-5. PubMed ID: 10540366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excretion of iron in response to deferoxamine in sickle cell anemia.
    Cohen A; Schwartz E
    J Pediatr; 1978 Apr; 92(4):659-62. PubMed ID: 633013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of haemoglobinopathies.
    Davies SC; Wonke B
    Baillieres Clin Haematol; 1991 Apr; 4(2):361-89. PubMed ID: 1912665
    [No Abstract]   [Full Text] [Related]  

  • 15. Subcutaneous bolus injection of deferoxamine in adult patients affected by onco-hematologic diseases and iron overload.
    Borgna-Pignatti C; Franchini M; Gandini G; Vassanelli A; De Gironcoli M; Aprili G
    Haematologica; 1998 Sep; 83(9):788-90. PubMed ID: 9825575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: two-year results including pharmacokinetics and concomitant hydroxyurea.
    Vichinsky E; Torres M; Minniti CP; Barrette S; Habr D; Zhang Y; Files B;
    Am J Hematol; 2013 Dec; 88(12):1068-73. PubMed ID: 23946212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid removal of excessive iron with daily, high-dose intravenous chelation therapy.
    Cohen AR; Mizanin J; Schwartz E
    J Pediatr; 1989 Jul; 115(1):151-5. PubMed ID: 2738783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial.
    Vichinsky E; Pakbaz Z; Onyekwere O; Porter J; Swerdlow P; Coates T; Lane P; Files B; Mueller BU; Coïc L; Forni GL; Fischer R; Marks P; Rofail D; Abetz L; Baladi JF
    Acta Haematol; 2008; 119(3):133-41. PubMed ID: 18408362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathy, neuropathic pain, and sickle cell disease.
    Ballas SK; Darbari DS
    Am J Hematol; 2013 Nov; 88(11):927-9. PubMed ID: 23963922
    [No Abstract]   [Full Text] [Related]  

  • 20. Deferasirox for managing transfusional iron overload in people with sickle cell disease.
    Meerpohl JJ; Antes G; Rücker G; Fleeman N; Niemeyer C; Bassler D
    Cochrane Database Syst Rev; 2010 Aug; (8):CD007477. PubMed ID: 20687088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.